| Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial | |
| Xu, Peng-Peng; Fu, Di; Li, Jian-Yong; Hu, Jian-Da; Wang, Xin; Zhou, Jian-Feng; Yu, Hao; Zhao, Xia; Huang, Yao-Hui; Jiang, Lu | |
| 2019 | |
| 卷号 | 6期号:6页码:E328-E337 |
| ISSN号 | 2352-3026 |
| DOI | 10.1016/S2352-3026(19)30051-1 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6340695 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Xu, Peng-Peng,Fu, Di,Li, Jian-Yong,et al. Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial[J],2019,6(6):E328-E337. |
| APA | Xu, Peng-Peng.,Fu, Di.,Li, Jian-Yong.,Hu, Jian-Da.,Wang, Xin.,...&Zhao, Wei-Li.(2019).Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial.,6(6),E328-E337. |
| MLA | Xu, Peng-Peng,et al."Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial".6.6(2019):E328-E337. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论